These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 9795025)
1. Rheological evaluation of poloxamer as an in situ gel for ophthalmic use. Edsman K; Carlfors J; Petersson R Eur J Pharm Sci; 1998 Apr; 6(2):105-12. PubMed ID: 9795025 [TBL] [Abstract][Full Text] [Related]
2. Poloxamer-based in situ gelling thermoresponsive systems for ocular drug delivery applications. Soliman KA; Ullah K; Shah A; Jones DS; Singh TRR Drug Discov Today; 2019 Aug; 24(8):1575-1586. PubMed ID: 31175956 [TBL] [Abstract][Full Text] [Related]
3. Optimization and evaluation of thermoresponsive diclofenac sodium ophthalmic in situ gels. Asasutjarit R; Thanasanchokpibull S; Fuongfuchat A; Veeranondha S Int J Pharm; 2011 Jun; 411(1-2):128-35. PubMed ID: 21459137 [TBL] [Abstract][Full Text] [Related]
4. [Preparation and properties of thermosensitive in situ gel for ophthalmic formulation containing pearl hydrolyzate]. Song LN; Li HR; Wang HY; Li Z; Zhao WC; Lu FZ; Li SM Yao Xue Xue Bao; 2016 Oct; 51(10):1622-8. PubMed ID: 29932618 [TBL] [Abstract][Full Text] [Related]
5. Rheological evaluation of Gelrite in situ gels for ophthalmic use. Carlfors J; Edsman K; Petersson R; Jörnving K Eur J Pharm Sci; 1998 Apr; 6(2):113-9. PubMed ID: 9795027 [TBL] [Abstract][Full Text] [Related]
6. Thermosetting gels with modulated gelation temperature for ophthalmic use: the rheological and gamma scintigraphic studies. Wei G; Xu H; Ding PT; Li SM; Zheng JM J Control Release; 2002 Sep; 83(1):65-74. PubMed ID: 12220839 [TBL] [Abstract][Full Text] [Related]
7. Formulation and development of ophthalmic in situ gel for the treatment ocular inflammation and infection using application of quality by design concept. Patel N; Thakkar V; Metalia V; Baldaniya L; Gandhi T; Gohel M Drug Dev Ind Pharm; 2016 Sep; 42(9):1406-23. PubMed ID: 26716613 [TBL] [Abstract][Full Text] [Related]
8. D-Optimal Design in the Development of Rheologically Improved In Situ Forming Ophthalmic Gel. Krtalić I; Radošević S; Hafner A; Grassi M; Nenadić M; Cetina-Čižmek B; Filipović-Grčić J; Pepić I; Lovrić J J Pharm Sci; 2018 Jun; 107(6):1562-1571. PubMed ID: 29421217 [TBL] [Abstract][Full Text] [Related]
9. Thermoresponsive ophthalmic poloxamer/tween/carbopol in situ gels of a poorly water-soluble drug fluconazole: preparation and in vitro-in vivo evaluation. Lihong W; Xin C; Yongxue G; Yiying B; Gang C Drug Dev Ind Pharm; 2014 Oct; 40(10):1402-10. PubMed ID: 23944837 [TBL] [Abstract][Full Text] [Related]
10. Temperature-responsive, Pluronic-g-poly(acrylic acid) copolymers in situ gels for ophthalmic drug delivery: rheology, in vitro drug release, and in vivo resident property. Ma WD; Xu H; Nie SF; Pan WS Drug Dev Ind Pharm; 2008 Mar; 34(3):258-66. PubMed ID: 18363141 [TBL] [Abstract][Full Text] [Related]
11. Effect of xanthan gum and guar gum on in situ gelling ophthalmic drug delivery system based on poloxamer-407. Bhowmik M; Kumari P; Sarkar G; Bain MK; Bhowmick B; Mollick MM; Mondal D; Maity D; Rana D; Bhattacharjee D; Chattopadhyay D Int J Biol Macromol; 2013 Nov; 62():117-23. PubMed ID: 23988556 [TBL] [Abstract][Full Text] [Related]
12. Development of a poloxamer analogs/carbopol-based in situ gelling and mucoadhesive ophthalmic delivery system for puerarin. Qi H; Chen W; Huang C; Li L; Chen C; Li W; Wu C Int J Pharm; 2007 Jun; 337(1-2):178-87. PubMed ID: 17254725 [TBL] [Abstract][Full Text] [Related]
13. New method for ophthalmic delivery of azithromycin by poloxamer/carbopol-based in situ gelling system. Cao F; Zhang X; Ping Q Drug Deliv; 2010; 17(7):500-7. PubMed ID: 20500130 [TBL] [Abstract][Full Text] [Related]
14. Novel in situ gelling ophthalmic drug delivery system based on gellan gum and hydroxyethylcellulose: Innovative rheological characterization, in vitro and in vivo evidence of a sustained precorneal retention time. Destruel PL; Zeng N; Seguin J; Douat S; Rosa F; Brignole-Baudouin F; Dufaÿ S; Dufaÿ-Wojcicki A; Maury M; Mignet N; Boudy V Int J Pharm; 2020 Jan; 574():118734. PubMed ID: 31705970 [TBL] [Abstract][Full Text] [Related]
15. [Real-time UV imaging of chloramphenicol intrinsic dissolution characteristics from ophthalmic in situ gel]. Chen JX; Guo Z; Li HY; Wu L; He ZG; Hu RF; Zhang JW Yao Xue Xue Bao; 2013 Jul; 48(7):1156-63. PubMed ID: 24133985 [TBL] [Abstract][Full Text] [Related]
16. Enhancing and sustaining the topical ocular delivery of fluconazole using chitosan solution and poloxamer/chitosan in situ forming gel. Gratieri T; Gelfuso GM; de Freitas O; Rocha EM; Lopez RF Eur J Pharm Biopharm; 2011 Oct; 79(2):320-7. PubMed ID: 21641994 [TBL] [Abstract][Full Text] [Related]
17. Comparison of thermosensitive in situ gels and drug-resin complex for ocular drug delivery: In vitro drug release and in vivo tissue distribution. Wei Y; Li C; Zhu Q; Zhang X; Guan J; Mao S Int J Pharm; 2020 Mar; 578():119184. PubMed ID: 32112932 [TBL] [Abstract][Full Text] [Related]
19. Influence of oleic acid on the rheology and in vitro release of lumiracoxib from poloxamer gels. Moreira TS; de Sousa VP; Pierre MB J Pharm Pharm Sci; 2010; 13(2):286-302. PubMed ID: 20816013 [TBL] [Abstract][Full Text] [Related]
20. [Rheological properties of poloxamer 407 aqueous solutions]. Hu J; Chen DW; Quan DQ Yao Xue Xue Bao; 2011 Feb; 46(2):227-31. PubMed ID: 21542295 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]